Acasti Pharma Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Laval Canada (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2011
NCT01455844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Acasti Pharma Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

krill oil (3 trials)

nimodipine (nimotop) (2 trials)

Drugs in Phase 2 Trials (1)

nkpl66 (1 trial)

Drugs in Phase 1 Trials (2)

betamethasone (celestone) (1 trial)

bupivacaine (Exparel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertriglyceridemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 5